Sales of savings-type and investment-type products to meet retirement funding and asset-building needs
First written in FY2022-Q3. 6 of 12 entries say "Restated". Latest entry: 2026-07-28.
3 other companies' latest entry also says "Restated".
- FY2025-H1RestatedAnnual report
「As in overall industry trends, the number of variable life insurance policies sold declined slightly, while the number of policies sold for savings and investment products such as individual annuities increased.」
The company reconfirms a sales mix in which the number of policies sold for savings and investment products such as individual annuities increased, while variable life insurance declined slightly. - FY2024-Q2RestatedAnnual report
「In line with industry trends, the number of policies sold for savings and investment products, including individual annuities and variable life insurance, continues to grow, as does the number of policies sold for products meeting medical coverage needs.」
The company reconfirms that, while sales are centered on savings and investment products such as individual annuities and variable life insurance, the number of policies sold for medical coverage products is also trending upward. - FY2024-Q1AdvancedAnnual report
「As in industry trends, the number of policies sold for savings and investment products, including individual annuities and variable life insurance, has increased. At the same time, the number of policies sold for products meeting medical coverage needs has also increased.」
The company explains that, in addition to savings and investment products such as individual annuities and variable life insurance, the number of policies sold for medical coverage products also increased. - FY2023RestatedAnnual report
「Against this backdrop, the company’s main life insurance products sold remained savings and investment products, including variable life insurance, as in the previous fiscal year.」
Against the backdrop of asset-building needs, the company reconfirms its sales mix centered on savings and investment products, including variable life insurance. - FY2023-Q3RestatedAnnual report
「In the third quarter, savings and investment products continued to be the main life insurance products sold in response to asset-building needs such as preparing living funds for retirement. Going forward, the company will provide financial planning, analyze customers’ household finances and assets, and propose insurance products suited to each customer.」
The company reconfirms its sales mix centered on savings and investment products and its policy of making proposals based on household and asset analyses by financial planners. - FY2023-Q2AdvancedAnnual report
「In the second quarter, savings and investment products continued to be the main life insurance products sold in response to asset-building needs such as preparing living funds for retirement. The number of sales of foreign-currency-denominated single-premium products increased, driven by high interest rates in the United States, and led the increase in new life insurance policies.」
The sales mix continues to be centered on savings and investment products, with sales of foreign-currency-denominated single-premium products increasing against the backdrop of high interest rates in the United States. - FY2023-Q1AdvancedAnnual report
「As in the previous fiscal year, savings-type and investment-type products continued to be the main focus of life insurance sales, in response to needs for asset building, including preparing funds for retirement. The number of new life insurance contracts during the cumulative first quarter was 45,185, while the number of contracts for foreign-currency-denominated products declined amid concerns about a US recession.」
The sales mix continues to be centered on savings and investment products, with 45,185 new life insurance policies reported for the quarter. - FY2022AdvancedAnnual report
「Sales volumes increased, centered on savings and investment products, in response to asset-building needs such as preparing living funds for retirement, which had continued to rise since the COVID-19 pandemic. In the fiscal year, the number of new life insurance policies was 185,911, up 36,288 from the end of the previous fiscal year, while new annualized premiums were ¥22,514,185 thousand, up ¥5,679,394 thousand over the same period.」
The company explains the increase in sales of savings and investment products in response to asset-building needs and presents full-year results for new policies and annualized premiums. - FY2022-Q3First statedAnnual report
「Sales volumes increased, centered on savings and investment products, in response to asset-building needs such as preparing living funds for retirement, which had continued to rise since the COVID-19 pandemic. In the cumulative third quarter, the number of new life insurance policies was 120,420, up 42,587 from the cumulative second quarter, while new annualized premiums were ¥15,235,318 thousand, up ¥5,515,857 thousand over the same period.」
The company presents its product mix as a means of addressing asset-building needs and reports the number of new policies and new annualized premiums.